MedTrace Logo

TEG 6s® for Perioperative Monitoring of Platelet Function During Cardiopulmonary Bypass for Cardiac Surgery

NCT04746560 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 6

Last updated 2022-01-31

No results posted yet for this study

Summary

Excessive bleeding is common during cardiopulmonary bypass (CPB) for cardiac surgery. This may result from the systemic activation of the coagulation pathway and the acquired platelet dysfunction during the procedure. This study aims to compare the diagnostic performances of the TEG®6S device and its Platelet mapping® cartridge to those of the "gold standard" tests (light transmittance aggregometry and Multiplate®) for platelet function monitoring in patients undergoing CPB for cardiac surgery.

Conditions

  • Cardiopulmonary Bypass

Interventions

DEVICE

TEG®6S device with its Platelet mapping® cartridge

Platelet function monitoring using the TEG®6S device with its Platelet mapping® cartridge

Sponsors & Collaborators

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Adrien BOUGLE, MD · Assistance Publique - Hôpitaux de Paris

  • Ahmed ABBES, MD · Assistance Publique - Hôpitaux de Paris

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-21
Primary Completion
2021-05-07
Completion
2021-05-07

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04746560 on ClinicalTrials.gov